10 research outputs found
Severe infections of Panton-Valentine leukocidin positive Staphylococcus aureus in children
Infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus (PVL-SA) mostly present as recurrent skin abscesses and furunculosis. However, life-threatening infections (eg, necrotizing pneumonia, necrotizing fasciitis, and osteomyelitis) caused by PVL-SA have also been reported.We assessed the clinical phenotype, frequency, clinical implications (surgery, length of treatment in hospitals/intensive care units, and antibiotic treatments), and potential preventability of severe PVL-SA infections in children.Total, 75 children treated for PVL-SA infections in our in- and outpatient units from 2012 to 2017 were included in this retrospective study.Ten out of 75 children contracted severe infections (PVL-methicillin resistant S aureus n = 4) including necrotizing pneumonia (n = 4), necrotizing fasciitis (n = 2), pyomyositis (n = 2; including 1 patient who also had pneumonia), mastoiditis with cerebellitis (n = 1), preorbital cellulitis (n = 1), and recurrent deep furunculosis in an immunosuppressed patient (n = 1). Specific complications of PVL-SA infections were venous thrombosis (n = 2), sepsis (n = 5), respiratory failure (n = 5), and acute respiratory distress syndrome (n = 3). The median duration of hospital stay was 14 days (range 5-52 days). In 6 out of 10 patients a history suggestive for PVL-SA colonization in the patient or close family members before hospital admission was identified.PVL-SA causes severe to life-threatening infections requiring lengthy treatments in hospital in a substantial percentage of symptomatic PVL-SA colonized children. More than 50% of severe infections might be prevented by prompt testing for PVL-SA in individuals with a history of abscesses or furunculosis, followed by decolonization measures
an observational study
Pulmonary tuberculosis (PTB) results in lung functional impairment and there
are no surrogate markers to monitor the extent of lung involvement. We
investigated the clinical significance of S100A12 and soluble receptor for
advanced glycation end-products (sRAGE) for predicting the extent of lung
involvement. We performed an observational study in India with 119 newly
diagnosed, treatment naïve, sputum smear positive, HIV-negative PTB patients
and 163 healthy controls. All patients were followed-up for six months.
Sociodemographic variables and the serum levels of S100A12, sRAGE, esRAGE,
HMGB-1, TNF-α, IFN-γ and CRP were measured. Lung involvement in PTB patients
was assessed by chest radiography. Compared with healthy controls, PTB
patients had increased serum concentrations of S100A12 while sRAGE was
decreased. S100A12 was an independent predictor of disease occurrence (OR
1.873, 95%CI 1.212–2.891, p = 0.004). Under DOTS therapy, S100A12 decreased
significantly after 4 months whereas CRP significantly decreased after 2
months (p < 0.0001). Importantly, although CRP was also an independent
predictor of disease occurrence, only S100A12 was a significant predictor of
lung alveolar infiltration (OR 2.60, 95%CI 1.35–5.00, p = 0.004). These
results suggest that S100A12 has the potential to assess the extent of
alveolar infiltration in PTB
An Observational Study in Hyderabad/India
Background Existing reading schemes for chest X-ray (CXR) used to grade the
extent of disease severity at diagnosis in patients with pulmonary
tuberculosis (PTB) are often based on numerical scores that summate specific
radiographic features. However, since PTB is known to exhibit a wide
heterogeneity in pathology, certain features might be differentially
associated with clinical parameters of disease severity. Objective We aimed to
grade disease severity in PTB patients at diagnosis and after completion of
DOTS treatment by developing a reading scheme based on five different
radiographic manifestations and analyze their association with the clinical
parameters of systemic involvement and infectivity. Methods 141 HIV-negative
adults with newly diagnosed sputum smear-positive PTB were enrolled in a
prospective observational study in Hyderabad, India. The presence and extent
on CXRs of five radiographic manifestations, i.e., lung involvement, alveolar
infiltration, cavitation, lymphadenopathy and pleural effusion, were
classified using the new reading scheme by using a four-quadrant approach. We
evaluated the inter-reader reliability of each manifestation, and its
association with BMI and sputum smear positivity at diagnosis. The presence
and extent of these radiographic manifestations were further compared with
CXRs on completion of DOTS treatment. Results At diagnosis, an average lung
area of 51.7% +/- 23.3% was affected by radiographic abnormalities. 94% of the
patients had alveolar infiltrates, with 89.4% located in the upper quadrants,
suggesting post primary PTB and in 34.8% of patients cavities were found. We
further showed that the extent of affected lung area was a negative predictor
of BMI (β value -0.035, p 0.019). No significant association of BMI with any
of the other CXR features was found. The extent of alveolar infiltrates, along
with the presence of cavitation, were strongly associated with sputum smear
positivity. The microbiological cure rate in our cohort after 6 months of DOTS
treatment was 95%. The extent of the affected lung area in these patients
decreased from 56.0% +/- 21.5% to 31.0 +/- 20% and a decrease was also
observed in the extent of alveolar infiltrates from 98.4% to 25.8% in at least
one quadrant, presence of cavities from 34.8% to 1.6%, lymphadenopathy from
46.8% to 16.1%, and pleural effusion from 19.4% to 6.5%. Conclusions We
established a new assessment scheme for grading disease severity in PTB by
specifically considering five radiographic manifestations which were
differently associated with the BMI and sputum smear positivity, changed to a
different extent after 6 months of treatment and exhibited an excellent
agreement between radiologists. Our results suggest that this reading scheme
might contribute to the estimation of disease severity with respect to
differences in disease pathology. Further studies are needed to determine a
correlation with short and long-term pulmonary function impairment and whether
there would be any benefit in lengthening or modulating therapy based on this
CXR severity assessment
Mediastinal mass in an tuberculosis-exposed 2-year old child with neurofibromatosis type 1 – TB or not TB?
A toddler with neurofibromatosis type 1 (NF1) was evaluated for tuberculosis (TB) after exposure. Chest X-ray (CXR) revealed a mediastinal mass indicating lymphadenopathy. However, magnetic resonance imaging showed a large plexiform thoracic neurofibroma. CXR performed for TB screening in NF1 patients cannot clearly differentiate lymphadenopathy from thoracic plexiform neurofibroma. Cross sectional imaging is therefore indicated for classification of mediastinal masses
Specific Chest Radiograph (CXR) features of lung involvement.
<p>(SD) standard deviation.</p><p>Specific Chest Radiograph (CXR) features of lung involvement.</p
Univariable linear regression: association of affected lung area with BMI
<p><b>Model parameters dependent variable BMI: Model 1</b> Constant 17.53 ANOVA 0.008, R<sup>2</sup> 0.044. <b>Model 2</b> Constant 18.22 ANOVA <0.0001, R<sup>2</sup> 0.087. <b>Model 3</b> Constant 18.21 ANOVA 0.002, R<sup>2</sup> 0.076.</p><p>Univariable linear regression: association of affected lung area with BMI</p
Chest Radiograph (CXR) results according to the presence of alveolar infiltrates in the upper or lower lung lobe.
<p>Chest Radiograph (CXR) results according to the presence of alveolar infiltrates in the upper or lower lung lobe.</p
Univariable and multivariable ordinal regression: association of alveolar infiltrates and cavities with number of bacteria in sputum smear.
<p><b>Dependent ordinal variable sputum smear (<1+, 1+, 2+ and 3+). Model 1</b> -2Log 52, Chi<sup>2</sup> 0.015, Goodness of fit 0.88, Pseudo R<sup>2</sup> (Cox and snell 0.084 and Nagelkerke 0.091), test of parallel lines 0.021. <b>Model 2</b> -2Log 27.5, Chi<sup>2</sup> 0.068, Goodness of fit 0.98, Pseudo R<sup>2</sup> (Cox and snell 0.037 and Nagelkerke 0.040), test of parallel lines 0.971. <b>Model 3</b> -2Log 53, Chi<sup>2</sup> 0,020, Goodness of fit 0,083, Pseudo R<sup>2</sup> (Cox and snell 0,067 and Nagelkerke 0,041), test of parallel lines 0,240. <b>Model 4</b> -2Log 158, Chi<sup>2</sup> 0.08, Goodness of fit 0,012, Pseudo R<sup>2</sup> (Cox and snell 0.11 and Nagelkerke 0.12), test of parallel lines 0.022. <b>Model 5</b> -2Log 100, Chi<sup>2</sup> 0.009, Goodness of fit 0,080, Pseudo R<sup>2</sup> (Cox and snell 0.11 and Nagelkerke 0.12), test of parallel lines 0.075. <b>Reference categories:</b> Sputum smear: 3+, Alveolar infiltrates: No infiltration, Cavities: 2 cavities.</p><p>Univariable and multivariable ordinal regression: association of alveolar infiltrates and cavities with number of bacteria in sputum smear.</p
Univariable logistic regression: association of CXR score based on the affected area of the lung and presence of cavitation with two-month sputum smear.
<p><b>Model parameters: Model 1</b> constant:- 2.22, -2Log likelihood 65.9-Chi<sup>2</sup> 0.31, Hosmer and lemeshow test <0.0001, R<sup>2</sup> (Cox 0.007 and Nagelkerke 0.019). <b>Model 2</b> constant:- 3.07, -2Log likelihood 66.7-Chi<sup>2</sup> 6.37, Hosmer and lemeshow test 0.206, R<sup>2</sup> (Cox 0.002 and Nagelkerke 0.004). <b>Model 3</b> constant:- 3.77, -2Log likelihood 65-Chi<sup>2</sup> 1.67, Hosmer and lemeshow test 0.446, R<sup>2</sup> (Cox 0.013 and Nagelkerke 0.036).</p><p>Univariable logistic regression: association of CXR score based on the affected area of the lung and presence of cavitation with two-month sputum smear.</p